Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL | 7MG | 0 | TERIFLUNOMIDE | TERIFLUNOMIDE |
002 | TABLET;ORAL | 14MG | 0 | TERIFLUNOMIDE | TERIFLUNOMIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-01-03 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2020-08-19 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
SANDOZ INC
cder:Array
(
[0] => Array
(
[ApplNo] => 209710
[companyName] => SANDOZ INC
[docInserts] => ["",""]
[products] => [{"drugName":"TERIFLUNOMIDE","activeIngredients":"TERIFLUNOMIDE","strength":"7MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TERIFLUNOMIDE","activeIngredients":"TERIFLUNOMIDE","strength":"14MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"01\/03\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-01-03
)
)